all is not well with prr, page-23

I do not understand all this fuss about PRR share price. I work at R&D (though in food, not pharma) where we run over a dozen of clinical trials per year. There is no way you CAN predict the success or failure of a clinical trial. The point is that for PRR (which I started holding again at 8 cents), the outcome is binary (as for any company betting on the clinical results): either a flop or a success. The downtrend is very understandable for a spec company with no substantial news in a pipeline until late 2013. It can go down to 5 cents, 4 cents or maybe not. At the end, it is either a 2 billion dollar company or nothing. What I do believe (judging by teh history of other biomed specs) is that before the clinical results are announced the share price will be pumped up by day traders well over 20 cents. So anyone who does not believe in the success of clinical trials will be able to get out prior to results announcement with a reasonable profit if they buy under 10 cents.